Interleukin 4 Gene–defective Mice Reconstituted with Wild-type Bone Marrow Fail to Produce Normal Immunoglobulin E Levels by Lange, Claudia et al.
 
1487
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/98/05/1487/07 $2.00
Volume 187, Number 9, May 4, 1998 1487–1493
http://www.jem.org
 
Interleukin 4 Gene–defective Mice Reconstituted with
Wild-type Bone Marrow Fail to Produce Normal
Immunoglobulin E Levels
 
By Claudia Lange, Thomas Schüler, and Thomas Blankenstein
 
From the Max-Delbrück-Center for Molecular Medicine, 13122 Berlin, Germany
 
Summary
 
The ability to reconstitute interleukin (IL)-4
 
2
 
/
 
2
 
 mice with bone marrow of IL-4
 
1
 
/
 
1
 
 mice was
investigated. The absence of the IL-4
 
2
 
/
 
2
 
 gene in donor or recipient cells did not impair the re-
constitution. All immunoglobulin (Ig) subsets occurred at normal serum levels except for IgE
and to some extent IgG1. IgE production did not recover in the reconstituted mice over pro-
longed time. However, these mice were competent for IgE production, because a single intra-
splenic injection of IL-4 restored IgE levels, which then remained constant. Wild-type mice
reconstituted with wild-type bone marrow constantly had IgE serum levels comparable to un-
treated animals. In wild-type mice reconstituted with IL-4
 
2
 
/
 
2
 
 bone marrow, IgE levels
dropped gradually and disappeared by week 12. We make three unrelated but nonetheless im-
portant conclusions: (
 
a
 
) (immunoregulation) the tightly regulated IL-4 gene should be ex-
pressed constantly in low amounts (and with apparent absence of antigen stimulation) to keep
the normal threshold of IgE; (
 
b
 
) (ontogeny of the immune system) an early unidentified source
of IL-4 must be postulated which is lost in adult mice; and (
 
c
 
) (bone marrow transfer/gene
therapy) under certain circumstances, the genotype of the recipient influences the reconstitu-
tion.
 
T
 
he production of immunoglobulin (Ig)E is under the
strict control of IL-4 (1–3). IL-4 is expressed by bone
marrow–derived cells (1). Its expression is tightly regulated
and considered to be essentially after antigen exposure. The
main source of IL-4 is CD4
 
1
 
 T cells of the Th2 subtype,
which paradoxically require IL-4 to be induced (1). It has
been suggested that NK1.1
 
1
 
 T cells initially provide IL-4
(4). However, the relative contribution of Th2 CD4
 
1
 
 T
cells and NK1.1
 
1
 
 T cells for IL-4–regulated immune re-
sponses and the time point of production of IL-4 by either
cell population in vivo are far from clear (4–10). The initial
production and contribution to immune-regulated pro-
cesses of IL-4 have been studied in vitro and in vivo after
exposure of animals to antigens known to be strong induc-
ers of IL-4. Yet IgE is constantly present in the serum in
considerable amounts (a few hundred nanograms per milli-
liter) even in the absence of apparent antigen. Its half-life in
serum is relatively short (5–12 h) (11–13). Therefore, new
IgE should be produced constitutively. Since the half-life
of IL-4 is even shorter (19 min after intravenous adminis-
tration) (14), one should postulate that IL-4 is also constitu-
tively produced. We prove here that this is indeed the case,
because in normal mice reconstituted with bone marrow
from IL-4
 
2
 
/
 
2
 
 mice, serum IgE levels declined during do-
nor cell reconstitution.
Vice versa, if IL-4
 
2
 
/
 
2
 
 mice are reconstituted with IL-4
 
1
 
/
 
1
 
bone marrow, the expectation would be that the mice do
establish normal IgE levels. This result would meet the
finding of others that reconstitution of gene-deficient mice
(e.g., genes for apolipoprotein E, 
 
b
 
-glucuronidase, com-
plement receptor CR2, TNF/lymphotoxin, or GM-CSF/
IL-3/IL-5 common receptor) with wild-type bone marrow
restores the normal phenotype (15–20). Surprisingly, IL-
4
 
2
 
/
 
2
 
 mice reconstituted with wild-type bone marrow re-
mained unable to produce the threshold IgE level, and thus
are defective for IL-4 production, even though they possess
the ability to secrete IL-4 and IgE. Our explanation is that
the cells initially producing IL-4 cannot be transferred with
adult bone marrow, dating initial IL-4 production back in
ontogeny.
 
Materials and Methods
 
Mice and Bone Marrow Transfer.
 
C57BL/6 (IL-4
 
1
 
/
 
1
 
) mice were
obtained from Bomholtgaard Breeding & Research Centre, Ry,
Denmark. IL-4–deficient mice (IL-4
 
2
 
/
 
2
 
) (2) were backcrossed for
eight generations to C57BL/6 mice and then intercrossed. All
mice were kept under specific pathogen–free conditions and
shown to be free of all viruses, parasites, and bacteria (except for
occasional 
 
Pasteurella pneumotropica
 
) by repeated controlling. Bone
marrow from 6–8-wk-old IL-4
 
1
 
/
 
1
 
 and IL-4
 
2
 
/
 
2
 
 female mice was
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harvested from both femurs and tibiae, and 1–2 
 
3
 
 10
 
7
 
 cells were
injected intravenously into lethally irradiated (9.5 Gy) 6–8-wk-old
female recipient mice. The following groups were included in the
experiments: IL-4
 
1
 
/
 
1
 
®
 
1
 
/
 
1
 
 (wild-type bone marrow transplanted
into wild-type mice), IL-4
 
1
 
/
 
1
 
®
 
2
 
/
 
2
 
, IL-4
 
2
 
/
 
2
 
®
 
1
 
/
 
1
 
, IL-4
 
2
 
/
 
2
 
®
 
2
 
/
 
2
 
,
and age-matched control animals. In two separate experiments,
18 animals per group were investigated.
 
ELISA for Serum Ig Detection.
 
At different time points (2, 4,
8, 12, and 16 wk, and in a second experiment, 48 wk after recon-
stitution), IgE levels were determined comparing serially diluted
serum with commercially available Ig standards. The following
reagents were used: R35-72 as capture antibody; purified mouse
IgE, clone 27-74, as standard; and biotinylated R35-118 as sec-
ondary antibody (all from PharMingen Europe, Hamburg, Ger-
many). For detection, avidin-peroxidase followed by 2,2
 
9
 
 azino-bis
(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS; both from Sigma
Chemical Co., Deisenhofen, Germany) was used according to
the manufacturer’s recommendations, and the color reaction was
read at 405 nm with a microplate ELISA reader (MR 5000; Dy-
natech Deutschland GmbH, Denkendorf, Germany). After long-
term reconstitution (5 mo), IgG2a, IgG2b, IgG3, IgM, and IgA
were detected in the sera of recipient mice using the Ig isotyping
kit according to the manufacturer’s recommendations (PharMin-
gen Europe), and IgG1 levels with G1-6.5 as capture antibody,
purified mouse IgG1, clone 107.3 as standard, and biotinylated
R8-140 as secondary antibody (all reagents from PharMingen
Europe). Except for IgG1, the amount of serum Igs in experi-
mental animals was expressed as a percentage of the serum Ig of
age-matched control animals.
 
PCR Analysis for Presence of Host/Donor-type Blood Cells.
 
5 mo
after reconstitution, 100 
 
m
 
l peripheral blood from four mice of
each group was collected by retroorbital puncture. DNA was
prepared using Sorb
 
Ò
 
 Twin Prep according to the manufacturer’s
recommendations (InViTek GmbH, Berlin, Germany). 
 
b
 
-Actin
primers were used to adjust to comparable concentrations of
DNA for 30 PCR cycles amplifying a 330-bp fragment. To de-
tect wild-type and knockout IL-4 alleles, the 5
 
9
 
 primer (5
 
9
 
-gCT
AgT TgT CAT CCT gCT CTTC) was located upstream, the 3
 
9
 
primer (5
 
9
 
-gCC gAT gAT CTC TCT CAA gTg) downstream of
the inserted 
 
neo
 
R
 
 gene within the IL-4 gene locus. The primers de-
tect a 1,200-bp fragment, provided the genomic DNA contains the
 
neo
 
R
 
 gene, and a 95-bp fragment in animals without the 
 
neo
 
R
 
 gene.
 
Peripheral Blood FACS
 
Ò
 
 Analysis of Reconstituted Mice.
 
5 mo after
bone marrow transplantation, 5 
 
3
 
 10
 
5
 
 peripheral blood cells of
four mice from each group were stained with 0.5 
 
m
 
g mAbs
against B220, CD4, CD8, and GR-1 for 30 min on ice. Isotype-
matched rat Ig was used as a control (all antibodies from Phar-
Mingen Europe). Stained cells were fixed on the Q-Prep workstation
with ImmunoPrep reagents, and analyzed using a flow cytometer
(EPICS-XL; Coulter Electronics GmbH, Krefeld, Germany).
 
Immunohistochemical Analysis of Cryosections and Bone Marrow
Cytospins.
 
Embedded organs (thymus, Peyers patches) of ani-
mals 8 mo after transplant were cut on a Microtom-Kryostat
HM500 OM (Microm Laborgeràte GmbH Life Sciences Interna-
tional GmbH, Walldorf, Germany). Cytospins (Shandon, Frank-
furt, Germany) of bone marrow cells were air-dried overnight
and stored at 
 
2
 
20
 
8
 
C until use. Cryosections and bone marrow
cytospins were fixed in ice-cold acetone for 10 min, air-dried,
and washed in PBS. All of the following steps were carried out in
a humid chamber. For anti-CD1d staining, preparations were
blocked with 5% normal goat serum in PBS for 30 min, stained
with 2 
 
m
 
g/ml anti-CD1d (PharMingen Europe) for 30 min, and
washed twice in PBS. Bound anti-CD1d was detected by incuba-
 
tion with Texas red–labeled goat anti–rat IgG (1:50; Serva Feih-
biochemica, Heidelberg, Germany). As negative control, goat
anti–rat IgG (TXRD) was used under the same conditions. For
NK1.1 and V
 
b
 
 8.1, 8.2 TCR detection, preparations were
blocked with 5% BSA in PBS and double-stained with 1 
 
m
 
g/ml
anti–NK1.1-PE plus 1 
 
m
 
g/ml anti–V
 
b
 
 8.1, 8.2 TCR-FITC
(PharMingen Europe) for 30 min. Isotype-matched Ig was in-
cluded as negative control. Stained preparations were mounted
with Kaiser’s glycerol gelatin (Merck, Darmstadt, Germany) and
analyzed on a fluorescence microscope (Olympus Optical Co.,
Ltd., Tokyo, Japan).
 
Infection with Nippostrongylus brasiliensis.
 
Mice (three C57BL/6
and three reconstituted IL-4
 
1
 
/
 
1
 
®
 
2
 
/
 
2
 
 mice 6 mo after transplant)
were injected subcutaneously with 500 third-stage 
 
N. brasiliensis
 
larvae. The serum IgE levels were determined before and 12 d af-
ter infection by ELISA as described above.
 
Injection of IL-4.
 
Three C57BL/6 and two reconstituted IL-
4
 
1
 
/
 
1
 
®
 
2
 
/
 
2
 
 mice 6 mo after transplant were injected intraspleni-
cally with 500 U IL-4, which is equivalent to 
 
z
 
50 ng (biological
activity 10
 
7
 
 U/mg; IC Chemikalien GmbH, Munich, Germany).
The serum IgE levels were determined before, and 7, 15, 28, and
42 d after injection by ELISA as described.
 
Results
 
Bone Marrow Reconstitution of IL-4 Congenic Mice.
 
Four
groups of bone marrow–reconstituted animals were gener-
ated: IL-4
 
1
 
/
 
1
 
 mice reconstituted with IL-4
 
1
 
/
 
1
 
 bone mar-
row (IL-4
 
1
 
/
 
1
 
®
 
1
 
/
 
1
 
); IL-4
 
2
 
/
 
2
 
 mice reconstituted with IL-4
 
1
 
/
 
1
 
bone marrow (IL-4
 
1
 
/
 
1
 
®
 
2
 
/
 
2
 
); IL-4
 
2
 
/
 
2
 
 mice reconstituted
with IL-4
 
2
 
/
 
2
 
 bone marrow (IL-4
 
2
 
/
 
2
 
®
 
2/2
 
); and IL-4
 
1
 
/
 
1
 
mice reconstituted with IL-4
 
2
 
/
 
2
 
 bone marrow (IL-4
 
2
 
/
 
2
 
® 
 
1
 
/
 
1
 
).
Age-matched untransplanted C57BL/6 animals served as
controls. To test the reconstitution of mice by donor cells,
recipients were analyzed by PCR for wild-type and dis-
rupted IL-4 gene in peripheral blood, hematopoietic cell
subset composition, and serum Ig levels 5 mo after bone
marrow transfer.
PCR analysis was done with primers close to the in-
serted neomycin sequence in the IL-4 gene, thus ampli-
fying a 1,200-bp fragment for the defective and a 95-bp frag-
ment for the wild-type allele. 5 mo after reconstitution, nearly
100% of peripheral blood cells in all four experimental groups
were of the donor type, comparing the IL-4
 
1
 
/
 
1
 
®
 
2
 
/
 
2
 
 and
IL-42/2®1/1 groups with the IL-41/1®1/1 and IL-42/2®2/2
groups (Fig. 1). Only in some mice of the IL-41/1®2/2
group were a few recipient cells left. Furthermore, hemato-
logical recovery of recipients was shown by similar num-
bers of B2201, CD41, CD81, and GR-11 cells in the pe-
ripheral blood among the different groups (data not
shown). Additionally, mice were analyzed 7 mo after trans-
plant for the presence of NK1.11 and Vb 8.1, 8.2 TCR1
cells in the bone marrow and CD1d1 cells in the Peyers
patches and thymus. This was done because NK1.11 T
cells preferentially using these TCRs occur at a comparably
high frequency in bone marrow, are restricted to the CD1d
antigen, and could be important for IL-4 production in the
transplanted mice (4). Regardless of the genotype of the
donor or recipient, NK1.11/Vb 8.1, 8.2 TCR1 and CD1d11489 Lange et al.
cells could easily be detected in the investigated specimen
(data not shown). Additional evidence for reconstitution
with functional donor cells was found by determination of
serum Ig isotypes IgG1, IgG2a, IgG2b, IgG3, IgA, and IgM in
long-term (5 mo) reconstituted mice (Fig. 2). All isotypes
except for IgG1 were found in quite similar amounts in mice
of all experimental groups. In mice of the IL-42/2®2/2
group, IgG1 was strongly reduced, but in IL-41/1®2/2 and
IL-42/2®1/1 animals, a statistically insignificant IgG1 re-
duction was observed. Whether this is related to IL-4 has
not been investigated. Taking the data together, there is no
reason to assume that the absence of the IL-4 gene in either
donor or recipient cells greatly impaired bone marrow re-
constitution.
Serum IgE Levels Require the Continuous Presence of a Func-
tional IL-4 Gene in Bone Marrow–derived Cells. We followed
IgE serum levels in the transplanted mice over time, con-
sidering that IgE production is a direct reflection of IL-4 ex-
pression (1–3). Normal untransplanted C57BL/6 mice
contained  z100 ng/ml IgE in serum at the age of 6–8 wk,
which increased to an average of 400 ng/ml over a period
of 3–4 mo (Fig. 3). IgE levels in mice of the IL-41/1®1/1
group at all time points closely resembled that in age-matched
C57BL/6 control animals. Mice from the IL-42/2®2/2 group
began and ended with no detectable IgE in the serum (detec-
tion limit 20 ng/ml). Mice in the IL-42/2®1/1 group had
normal serum IgE levels until 4 wk after transplantation,
which then dropped and disappeared completely in all ani-
mals by week 12 (Fig. 3). Because the only difference be-
tween the IL-41/1®1/1 and IL-42/2®1/1 groups is the
presence or absence of a functional IL-4 gene in donor
cells, we make three conclusions: (a) IL-4 is indeed only
produced by bone marrow–derived cells and is mandatory
for IgE production; (b) recipient cells in the IL-42/2®1/1
group seem to produce IL-4 continuously early after irradi-
ation until they are replaced by donor cells at week 12 at
the latest; and (c) the constant IgE levels in the IL-41/1®1/1
group can best be explained by a constitutive IL-4 produc-
tion in the mice. All animals were kept under specific
pathogen–free conditions and had no apparent contact
with bacteria, viruses, or parasites, though this does not ex-
clude the possibility that the measured IgE was induced by
exogenous antigens undetectable by us.
Bone Marrow–derived Cells from Adult IL-41/1 Mice Are
Unable to Induce Threshold IgE Levels in IL-42/2 Recipients.
Considering the results with mice from the IL-42/2®1/1
Figure 1. Peripheral blood cells of bone
marrow–transplanted IL-4 congenic mice
are of the donor cell type. 5 mo after recon-
stitution, four animals of each transplanted
group were examined for host or donor cell
types in peripheral blood. After equalization
with b-actin primers (data not shown), ge-
nomic peripheral blood DNA was subjected
to PCR using primers located in the vicin-
ity of the inserted neoR gene. DNA contain-
ing the neoR gene gives rise to a 1,200-bp
band and wild-type DNA to a 95-bp band.
Figure 2. Analysis of serum Ig levels in bone marrow–reconstituted IL-4
congenic mice. 5 mo after reconstitution, serial dilutions of mouse sera were
analyzed in an Ig-isotyping ELISA for IgM, IgG3, IgG1, IgG2b, IgG2a,
and IgA. Except for IgG1, serum Ig amounts for age-matched control an-
imals were set at 100%. Data represent mean 6 SD of eight animals.1490 Bone Marrow Transplantation of Interleukin-4–deficient Mice
group, one would expect that IL-41/1®2/2 mice start to
make IgE as a result of the functional IL-4 gene in bone
marrow–derived cells by week 12 at the latest. However,
IgE levels in mice of this group remained undetectable in
almost all animals until week 16 and beyond after trans-
plantation. Fig. 3 shows the serum IgE levels from one ex-
periment using eight mice for each experimental group for
up to 16 wk. In a second experiment, 10 animals of the IL-
41/1®2/2 group were measured for serum IgE levels 48 wk
after transplantation. Again, IgE was undetectable in serum
of most animals (8/10). However, as we have seen above,
IL-41/1 bone marrow–derived cells are very well able to
produce IgE, if transplanted into IL-41/1 hosts where in
the early reconstitution phase, IL-4 is probably provided by
the host. We conclude that IL-41/1 bone marrow–derived
cells do not have the ability to induce threshold IgE levels
in IL-42/2 hosts.
IL-41/1 Bone Marrow–derived Cells in IL-42/2 Recipients
Can Be Induced to Produce IgE. Despite the fact that IL-
41/1®2/2 mice seemed to be reconstituted in a normal
way (see above) and IL-41/1 bone marrow–derived cells
were able to initiate IgE expression in an appropriate envi-
ronment, we could not exclude a hematologic impairment
resulting from secondary effects, e.g., defective IgE expres-
sion in mice of the IL-41/1®2/2 group resulting from par-
tial graft failure in the IL-42/2 hosts undetectable by us.
Therefore, mice from the IL-41/1®2/2 group received a
single intrasplenic injection of 500 U IL-4, and IgE serum
levels were followed over time (Fig. 4). Within 7 d, IgE
was detectable in serum, and at day 14 after IL-4 injection,
IgE levels were comparable to normal C57BL/6 mice
treated in the same way. Remarkably, IgE levels remained
constant throughout the experiment (day 42), which can
best be explained by endogenous IL-4 induced through ex-
ogenous IL-4, which subsequently regulated a normal
threshold of IgE in serum. Additionally, 6 mo after recon-
stitution, IL-41/1®2/2 animals were challenged with N.
brasiliensis larvae, a strong natural IL-4 inducer. This led to
an z10-fold increase in serum IgE in normal mice after 12 d
(Fig. 5). In IL-41/1®2/2 mice, similar IgE levels were
reached. Thus, defective IgE production in mice carrying a
functional IL-4 gene in bone marrow–derived cells can be
overcome by a strong IL-4–inducing stimulus.
Discussion
The question of which mechanism initiates IL-4 expres-
sion and subsequent IgE production has been studied
mainly after antigenic stimulation. The stimuli used were
strong inducers of IL-4 production, such as nematodes (1),
Figure 3. Serum IgE levels of bone mar-
row–reconstituted IL-4 congenic mice. Serum
IgE levels were determined by an IgE-specific
ELISA at indicated time points, comparing
serial dilutions of sera with a commercial IgE
standard. Groups of animals included were
as follows: IL-41/1®1/1 (s), IL-41/1®2/2
(d), IL-42/2®1/1 ( u ), IL-42/2®2/2 ( j ),
and age-matched control animals (m).
Shown are data from (A) eight individual
animals, including the mean value for each
group (black bar) up to 16 wk after transplan-
tation. Similar results were obtained in a
second experiment with 10 animals in each
group. A third group of IL-41/1®2/2 mice
was established, and IgE serum levels were
determined after 48 wk. (B) Mean IgE lev-
els of mice shown in A. Detection limit of
the IgE ELISA was 20 ng/ml.1491 Lange et al.
polyclonal stimuli like anti-CD3 and anti-IgD (21),
chronic antigen exposure (5), or adjuvant preferentially in-
ducing Th2 responses such as alum (5, 22). Depending on
the experimental system, CD41 T cells (5), NK1.11 T cells
(21), or eosinophils (23) were responsible for initial IL-4
production. We addressed this question from a different
point of view, considering that serum IgE levels are present
in young animals without experimental antigenic stimula-
tion. It has been shown that serum IgE is undetectable in
nonimmunized IL-42/2 mice and that even nematode in-
fection fails to induce IgE expression in the absence of a
functional IL-4 gene (2, 3). Therefore, we purposely mea-
sured serum IgE levels in the bone marrow–reconstituted
animals, because it directly reflects IL-4 expression and be-
cause IL-4 is difficult to measure in naive animals. We used
low IgE responder C57BL/6 mice, which in a pathogen-
poor environment contain 70 ng/ml IgE in serum at the
age of 6–8 wk, increasing to 400 ng/ml at the age of 5–6
mo on the average. Using bone marrow chimeras with IL-
42/2 mice, we showed that these IgE levels depend com-
pletely on the ability of the mice to express IL-4, and that
their maintenance depends on the continuous presence of a
functional IL-4 gene in bone marrow–derived cells. This
was shown in mice of the IL-42/2®1/1 group, where IgE
serum levels declined rapidly, proportional to replacement
of IL-4–competent by IL-4–incompetent cells. Thus, tak-
ing into account sustained IgE serum levels in the IL-
41/1®1/1 mice over a long time period and the compara-
bly short half-lives of both IgE (11–13) and IL-4 (14), it
becomes apparent that IL-4 should be constitutively ex-
pressed even though the animals were not exposed to any
overt antigenic stimulus. It is not known which IL-4–pro-
ducing cells are responsible for threshold IgE serum levels.
IgE expression in mice of the IL-42/2®1/1 group must not
necessarily reflect B cells induced by the recipient’s IL-4 to
switch to IgE expression after irradiation. Recently, it has
been shown that the life-time of plasma cells which secrete
ovalbumin-specific IgG1 antibodies in the bone marrow
can be as long as 90 d without DNA synthesis (24). The
observation that IgE serum levels in IL-42/2®1/1 mice dis-
appeared within z8 wk indicates that the half-life of IgE-
secreting plasma cells in bone marrow–reconstituted mice
is shorter.
Our most important finding was that IL-42/2 mice re-
constituted with IL-41/1 bone marrow failed to establish
normal IgE serum levels. Two control experiments showed
that this defect was caused by the absence in adult bone
marrow of cells from which the initially IL-4–providing
cells derive. In the first, if IL-41/1 bone marrow was trans-
planted into IL-41/1 mice, the animals continued to pro-
duce normal serum IgE levels. Therefore, IL-41/1 bone
marrow–derived cells are able to produce IL-4 and IgE. In
the IL-41/1 recipient mice, IL-4 and concomitantly IgE
might be produced for a certain period after lethal irradia-
tion and bone marrow transfer. This period can be esti-
mated in the IL-42/2®1/1 group of mice, lasting between
6 and 8 wk after transplantation. During replacement of re-
cipient by donor cells, donor bone marrow–derived cells
are educated by the recipient’s IL-4 to produce IL-4 them-
selves and subsequently to maintain threshold serum IgE
levels. In the second control experiment, in mice of the IL-
41/1®2/2 group, defective IgE production could be res-
cued by a single injection of IL-4, ruling out partial graft
failure as the reason for the defect. Because these mice con-
tinued to produce IgE throughout the experiment (42 d),
the exogenous IL-4 should have induced IL-4 expression
in donor-derived cells. Once initiated, IL-4 expression acts
in an autostimulatory fashion. Therefore, our results dem-
onstrate that bone marrow cells of adult animals are unable
to give rise to cells from which IL-4 first originates, and
thus are functionally not pluripotent. This raises the ques-
tion of when and by which cells initial IL-4 is provided.
We offer two not mutually exclusive explanations. First,
IL-4 is expressed during early development. This is sup-
ported by the observation that IL-4 mRNA as well as IL-4
receptor mRNA could be detected in 10.5- and 12.5-d-old
embryos (25). In extracts of some tissues (e.g., liver) of
12.5-d-old fetuses, IL-4 protein could also be detected.
Furthermore, hematopoietic progenitor cells differentiated
in vitro from embryonic stem cells express IL-4 and IL-4
receptor mRNA (26). Second, IL-4 is provided by the
mother. This alternative is supported by the observation
that pregnant mice (27–29) and women (30) produce in-
creased amounts of IL-4, and IL-4 mRNA is detected in
uterine decidual plus placental tissue at days 8.5–12.5 of
gestation (25). We currently analyze these two possibilities.
However, regardless of whether induction of the IL-4–reg-
ulated network results from “maternal imprinting” or from
the expression of IL-4 by embryonic cells, the fetus is ex-
posed to IL-4, and the initial source of IL-4 is not necessary
any more in the adult because the system keeps itself alive.
Figure 4. Defective IgE pro-
duction in IL-41/1®2/2 mice
can be rescued by exogenous IL-4.
Wild-type and IL-41/1®2/2
bone marrow–reconstituted mice
(6 mo after transplant) were in-
jected intrasplenically with 500 U
(z50 ng) IL-4, and serum IgE
levels were determined before
(d0), 7, 15, 28, and 42 d (d42) af-
ter injection. Data represent
mean  6 SD of three and two
mice, respectively.
Figure 5. Defective IgE pro-
duction in IL-41/1®2/2 mice
can be rescued by N. brasiliensis.
Wild-type and IL-41/1®2/2 re-
constituted mice 7 mo after trans-
plant were injected subcutane-
ously with third-stage larvae of
N. brasiliensis, and serum IgE lev-
els were analyzed before (d0) and 12 d (d12) after injection. Data repre-
sent mean 6 SD of three animals.1492 Bone Marrow Transplantation of Interleukin-4–deficient Mice
IgE production in mice of the IL-41/1®2/2 group can
also be rescued by challenge with larvae of N. brasiliensis,
further supporting that normal hematopoietic reconstitu-
tion had occurred in the animals. Even though it has been
shown that the IL-4 requirement for IgE production can be
bypassed by some antigens such as Plasmodium chabaudi or a
mouse retrovirus (31, 32), IgE production in the bone mar-
row–reconstituted mice after nematode exposure probably
occurs in an IL-4–dependent way, because IL-42/2 mice
fail to produce detectable amounts of IgE after nematode
challenge (2, 3). However, we think it is unlikely that
strong IL-4 inducers such as nematodes are the driving
force for establishing the IL-4–regulated immune system in
early life.
For a variety of genetic diseases, bone marrow reconsti-
tution with cells genetically modified to carry a functional
copy of the defective gene is considered to be a therapeutic
modality. Wild-type bone marrow transplantation into
gene-deficient mice has been shown in several models to
restore a normal phenotype (15–20). Our results differ in
this regard and raise the caution that for certain genes, e.g.,
those involved in regulation of hematopoiesis, gene therapy
approaches encounter problems not anticipated previously.
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